These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 994514)

  • 1. Patterns of serial CEA assays and their clinical use in management of colorectal cancer.
    Sugarbaker PH; Skarin AT; Zamcheck N
    J Surg Oncol; 1976; 8(6):523-37. PubMed ID: 994514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carcinoembryonic antigen (CEA) monitoring of radiation therapy for colorectal cancer.
    Sugarbaker PH; Bloomer WD; Corbett ED; Chaffey JT
    AJR Am J Roentgenol; 1976 Oct; 127(4):641-4. PubMed ID: 970537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen (CEA): its role as a monitor of radiation therapy for colorectal cancer.
    Sugarbaker PH; Bloomer WD; Corbett ED; Chaffey JT
    Cancer; 1978 Sep; 42(3 Suppl):1434-6. PubMed ID: 709512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colon-specific antigen-p (CSAp). I. Initial clinical evaluation as a marker for colorectal cancer.
    Pant KD; Shochat D; Nelson MO; Goldenberg DM
    Cancer; 1982 Sep; 50(5):919-26. PubMed ID: 6178498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer.
    Mayer RJ; Garnick MB; Steele GD; Zamcheck N
    Cancer; 1978 Sep; 42(3 Suppl):1428-33. PubMed ID: 709511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
    Wanebo HJ
    Surgery; 1981 Mar; 89(3):290-5. PubMed ID: 7466616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of tumor markers in the management of colorectal cancer.
    Go VL; Zamcheck N
    Cancer; 1982 Dec; 50(11 Suppl):2618-23. PubMed ID: 7139557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of serial carcinoembryonic antigen (CEA) assays in postoperative detection of recurrent colorectal cancer.
    Sugarbaker PH; Zamcheck N; Moore FD
    Cancer; 1976 Dec; 38(6):2310-5. PubMed ID: 1000469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoembryonic antigen: clinical and historical aspects.
    Martin EW; Kibbey WE; DiVecchia L; Anderson G; Catalano P; Minton JP
    Cancer; 1976 Jan; 37(1):62-81. PubMed ID: 1247968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial levels of CA 19-9 and CEA in colonic cancer.
    Novis BH; Gluck E; Thomas P; Steele GD; Zurawski VR; Stewart R; Lavin PT; Zamcheck N
    J Clin Oncol; 1986 Jun; 4(6):987-93. PubMed ID: 2423655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen: 3 years' experience in a cancer clinic.
    Koch M; McPherson TA; Morrish DW
    Can Med Assoc J; 1977 Apr; 116(7):769-71. PubMed ID: 849560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen (CEA) assays in obstructive colorectal cancer.
    Sugarbaker PH
    Ann Surg; 1976 Dec; 184(6):752-7. PubMed ID: 999351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of CEA in colorectal carcinoma].
    Shimoyama T; Fukuda Y; Itoh S; Shimizu T; Kawaguchi A; Mori M; Ishii T; Miura T; Tomita M
    Gan No Rinsho; 1985 May; 31(6 Suppl):648-54. PubMed ID: 3897618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of the pattern of elevated serum carcinoembryonic antigen (CEA) levels in recurrent colorectal cancer.
    Wood CB; Ratcliffe JG; Burt RW; Malcolm AJ; Blumgart LH
    Br J Surg; 1980 Jan; 67(1):46-8. PubMed ID: 7357243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial CEA levels in colorectal carcinoma on adjuvant immuno (chemo) therapy.
    Carluccio L; Colizza S; Costantino A; Di Paola M; Sopranzi N
    J Surg Oncol; 1978; 10(6):511-7. PubMed ID: 732334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes (CIC), carcinoembryonic antigen (CEA) and CIC containing CEA as markers for colorectal cancer.
    Chester KA; Begent RH
    Clin Exp Immunol; 1984 Dec; 58(3):685-93. PubMed ID: 6509799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in patients following clinically curative resection of colorectal cancer.
    Steele G; Sonis S; Stelos P; Rittgers R; Zamcheck N; Finn D; Maltz J; Mayer R; Lokich J; Wilson RE
    Surgery; 1978 Jun; 83(6):648-54. PubMed ID: 205963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of CEA in colorectal cancer: a statistical study.
    Persijn JP; Hart AA
    J Clin Chem Clin Biochem; 1981 Nov; 19(11):1117-23. PubMed ID: 7310333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma.
    Shani A; O'Connell MJ; Moertel CG; Schutt AJ; Silvers A; Go VL
    Ann Intern Med; 1978 May; 88(5):627-30. PubMed ID: 646245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA.
    Gade M; Kubik M; Fisker RV; Thorlacius-Ussing O; Petersen LJ
    Cancer Imaging; 2015 Aug; 15(1):11. PubMed ID: 26263901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.